Organization
Sourasky Medical Center, Tel Aviv, Israel
4 abstracts
Abstract
Livmoniplimab with or without budigalimab in patients with advanced solid tumors: Results from the combination therapy in the urothelial carcinoma dose expansion cohort.Org: Hospital Clínico Universitario-INCLIVIA, Valencia, Spain, Universite Catholique De Louvain, Bruxelles, Belgium, Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, VA New York Harbor Healthcare System, Manhattan Campus, New York, NY, Yonsei University Health System and Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea,
Abstract
Body and mind and self-consciousness awareness workshops: Improving quality of life in patients with cancer.Org: Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, Tel Aviv-Yafo, Israel, Sourasky Medical Center, Tel Aviv, Israel, Division of Oncology, Rambam health care, Haifa, Israel,
Abstract
Real-world behavioral restrictional practices of cancer patients (pts).Org: Sourasky Medical Center, Tel Aviv, Israel, Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, Tel Aviv Sourasky Medical center, Tel Aviv, Israel, Tel Aviv-Yafo, Israeli Medical Research Center, Research Unit “Dr. Mirko Grmek,” Psychiatric Clinic “Sveti Ivan”,
Abstract
Clinical predictors of survival in advanced epithelial ovarian cancer: Can we foresee the long-term survivors and develop a personalized treatment approach?Org: Tel Aviv Sourasky Medical Center, Division of Oncology, Rambam health care, Haifa, Israel, Sourasky Medical Center, Tel Aviv, Israel, RGS Unit, Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, Tel Aviv Sourasky Medical center, Tel Aviv, Israel,